Skip to content
The Policy VaultThe Policy Vault

CinqairMedica

severe asthma with an eosinophilic phenotype

Preferred products

  • Fasenra
  • Nucala

Initial criteria

  • Patient meets the standard Immunologicals – Cinqair Prior Authorization Policy criteria
  • Patient has tried at least one preferred product (Fasenra or Nucala) OR meets exception criteria

Approval duration

as noted in the respective Immunologicals Prior Authorization Policy